SCAVONE, Cristina
 Distribuzione geografica
Continente #
EU - Europa 5.215
AS - Asia 1.945
NA - Nord America 1.648
SA - Sud America 451
AF - Africa 27
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 1
Totale 9.289
Nazione #
RU - Federazione Russa 3.732
US - Stati Uniti d'America 1.613
SG - Singapore 702
IE - Irlanda 523
CN - Cina 399
BR - Brasile 384
IT - Italia 326
HK - Hong Kong 307
VN - Vietnam 199
DE - Germania 176
GB - Regno Unito 158
KR - Corea 99
UA - Ucraina 84
JP - Giappone 64
IN - India 51
GR - Grecia 48
FI - Finlandia 33
TR - Turchia 30
AR - Argentina 25
BD - Bangladesh 20
FR - Francia 19
SE - Svezia 18
EC - Ecuador 17
CA - Canada 16
ID - Indonesia 14
AT - Austria 12
CZ - Repubblica Ceca 12
IQ - Iraq 11
PL - Polonia 11
BE - Belgio 10
MX - Messico 10
NL - Olanda 10
ZA - Sudafrica 10
CO - Colombia 9
ES - Italia 9
UZ - Uzbekistan 9
AL - Albania 7
SC - Seychelles 7
CL - Cile 5
IR - Iran 5
PK - Pakistan 5
VE - Venezuela 5
CH - Svizzera 4
KG - Kirghizistan 4
NP - Nepal 4
PY - Paraguay 4
RS - Serbia 4
SA - Arabia Saudita 4
BG - Bulgaria 3
DK - Danimarca 3
MA - Marocco 3
PR - Porto Rico 3
TN - Tunisia 3
AE - Emirati Arabi Uniti 2
EE - Estonia 2
EU - Europa 2
GE - Georgia 2
IL - Israele 2
JM - Giamaica 2
KE - Kenya 2
KW - Kuwait 2
LV - Lettonia 2
NO - Norvegia 2
PE - Perù 2
RO - Romania 2
SY - Repubblica araba siriana 2
AM - Armenia 1
BB - Barbados 1
BH - Bahrain 1
DO - Repubblica Dominicana 1
EG - Egitto 1
GA - Gabon 1
HN - Honduras 1
HU - Ungheria 1
IS - Islanda 1
JO - Giordania 1
KI - Kiribati 1
LA - Repubblica Popolare Democratica del Laos 1
LT - Lituania 1
MD - Moldavia 1
MY - Malesia 1
OM - Oman 1
PS - Palestinian Territory 1
PT - Portogallo 1
QA - Qatar 1
TT - Trinidad e Tobago 1
Totale 9.289
Città #
Moscow 1.318
Dublin 520
Singapore 326
Santa Clara 307
Hong Kong 306
Chandler 195
Jacksonville 157
Seoul 97
Ashburn 96
Bremen 70
Princeton 69
Roxbury 69
Beijing 68
Hefei 63
Dong Ket 60
Ho Chi Minh City 53
Medford 46
Ann Arbor 38
São Paulo 38
The Dalles 37
Caserta 34
Aversa 32
Munich 30
Naples 29
Bengaluru 28
Hanoi 26
Napoli 24
Wilmington 24
Cambridge 23
Dallas 21
Los Angeles 20
New York 19
Woodbridge 18
Des Moines 17
Rio de Janeiro 15
Nuremberg 13
Nanjing 12
Salerno 12
Brno 11
Falkenstein 11
Hanover 11
Brussels 10
Helsinki 10
Milan 10
Mountain View 9
Jinan 8
London 8
Tashkent 8
Toronto 8
Brasília 7
Changsha 7
Columbus 7
Curitiba 7
Guangzhou 7
Jakarta 7
Johannesburg 7
Mexico City 7
Norwalk 7
Turku 7
Atlanta 6
Boardman 6
Düsseldorf 6
Kunming 6
Redwood City 6
San Francisco 6
Auburn Hills 5
Baghdad 5
Belo Horizonte 5
Biên Hòa 5
Da Nang 5
Dearborn 5
Guayaquil 5
Istanbul 5
Piracicaba 5
Quito 5
Tirana 5
Vienna 5
Warsaw 5
Wroclaw 5
Amsterdam 4
Asunción 4
Bogotá 4
Bologna 4
Groningen 4
Hải Dương 4
Newark 4
Padova 4
Pouso Alegre 4
Rome 4
Stockholm 4
Tokyo 4
Viterbo 4
Afragola 3
Athens 3
Beckenham 3
Belgrade 3
Betim 3
Bishkek 3
Brooklyn 3
Caivano 3
Totale 4.686
Nome #
Amelioration of diastolic dysfunction by dapagliflozin in a non-diabetic model involves coronary endothelium 184
Campania preventability assessment committee (Italy): A focus on the preventability of non-steroidal anti-inflammatory drugs' adverse drug reactions 166
Safety profile of anticancer and immune-modulating biotech drugs used in a real world setting in Campania Region (Italy): BIO-Cam observational study 164
Angiotensin II and angiotensin 1-7: which is their role in atrial fibrillation? 162
Campania Region (Italy) spontaneous reporting system and preventability assessment through a case-by-case approach: a pilot study on psychotropic drugs 161
Contrast media-induced nephropathy: how has Italy contributed in the past 30 years? A systematic review 159
Antidepressant-Induced Acute Liver Injury: A Case-Control Study in an Italian Inpatient Population 156
Dipeptidyl Peptidase 4 Inhibition Ameliorates Chronic Kidney Disease in a Model of Salt-Dependent Hypertension 155
Campania preventability assessment committee: a focus on the preventability of the contrast media adverse drug reactions 147
Medication adherence and the use of new pharmaceutical formulations: The case of levothyroxine 142
Atomoxetine in the treatment of attention deficit hyperactivity disorder and suicidal ideation 139
Adverse drug reactions during hepatitis C treatment with direct-acting antivirals: The role of medication errors, their impact on treatment discontinuation and their preventability. New insights from the Campania Region (Italy) spontaneous reporting system 138
Biosimilars in the European Union from comparability exercise to real world experience: What we achieved and what we still need to achieve 136
Comparison of long-term clinical implications of beta-blockade in patients with obstructive airway diseases exposed to beta-blockers with different β1-adrenoreceptor selectivity: An Italian population-based cohort study 135
Effects of ranolazine in a model of doxorubicin-induced left ventricle diastolic dysfunction 135
Current pharmacological treatments for COVID-19: What's next? 129
Correction to: Angiotensin II and angiotensin 1–7: which is their role in atrial fibrillation? (Heart Failure Reviews, (2020), 10.1007/s10741-020-09961-9) 128
Cardiac Events Potentially Associated to Remdesivir: An Analysis from the European Spontaneous Adverse Event Reporting System 127
Did the new Italian law on mandatory vaccines affect adverse event Following immunization's reporting? A pharmacovigilance study in Southern Italy 126
Can causality assessment fulfill the new European definition of adverse drug reaction? A review of methods used in spontaneous reporting( 124
Neurological Manifestations Related to Immune Checkpoint Inhibitors: Reverse Translational Research by Using the European Real-World Safety Data 123
The importance of Pharmacovigilance for the drug safety: Focus on cardiovascular profile of incretin-based therapy 120
Disclosing negative trial results – procedure 120
Changes in Anthropometric Parameters After Anti-TNFα Therapy in Inflammatory Bowel Disease: A Systematic Review and Meta-analysis 120
Skin Toxicities Associated with Botulin Toxin Injection for Aesthetic Procedures: Data from the European Spontaneous Reporting System 119
Blood-based PD-L1 analysis in tumor-derived extracellular vesicles: Applications for optimal use of anti-PD-1/PD-L1 axis inhibitors 117
Disclosure of negative trial results. A call for action 116
Hepatobiliary Adverse Reactions during Treatment with Cladribine: Analysis of Data from the European Spontaneous Reporting System 112
Pregnancy Recommendations Solely Based on Preclinical Evidence Should Be Integrated with Real-World Evidence: A Disproportionality Analysis of Certolizumab and Other TNF-Alpha Inhibitors Used in Pregnant Patients with Psoriasis 111
Combining liquid biopsy and radiomics for personalized treatment of lung cancer patients. State of the art and new perspectives 109
Gender differences in outpatient pediatric drug utilization: A cohort study from southern Italy 107
Efficacy and safety of insulin-GLP-1 receptor agonists combination in type 2 diabetes mellitus: a systematic review 106
The Role of Renin-Angiotensin-Aldosterone System in the Heart and Lung: Focus on COVID-19 106
Hypogammaglobulinemia in patients with multiple sclerosis receiving disease modifying therapies: disproportionality analysis using the EudraVigilance database 104
T-cell malignancies following CAR T-Cell therapy: insights from the FDA Adverse Event Reporting System (FAERS) 104
New era in treatment options of chronic hepatitis C: focus on safety of new direct-acting antivirals (DAAs) 104
The Safety Profile of COVID-19 Vaccines in Patients Diagnosed with Multiple Sclerosis: A Retrospective Observational Study 103
Association between the glyco-metabolic adverse effects of antipsychotic drugs and their chemical and pharmacological profile: A network meta-analysis and regression 103
Mid-term follow-up after COVID-19 vaccination in adults with CHD: a prospective study 102
Safety of dapagliflozin and empagliflozin in cases with diabetes mellitus or/and heart failure: a retrospective pharmacovigilance study conducted on the eudravigilance database 99
Influenza vaccine hesitancy in patients with multiple sclerosis: A monocentric observational study 98
The Potential Benefits of a Novel Food Supplement Based on Cannabis Sativa, Boswellia, and Fish Oil for Pain and Inflammation in Physical Activity: Unraveling the Role of Orexin-A Modulation 97
Severe Multiple Sclerosis Relapse After COVID-19 Vaccination: A Case Report 97
Disproportionality analysis of European safety reports on autoimmune and rheumatic diseases following COVID-19 vaccination 96
New and old roles of the peripheral and brain renin–angiotensin–aldosterone system (RAAS): Focus on cardiovascular and neurological diseases 96
Safety of Anticancer Agents Used in Children: A Focus on Their Off-Label Use Through Data From the Spontaneous Reporting System 95
Immune Checkpoint Inhibitors and Immune-Related Adverse Drug Reactions: Data From Italian Pharmacovigilance Database 95
The Use of Botulinum Toxin Type A and the Occurrence of Anaphylaxis: A Descriptive Analysis of Data from the European Spontaneous Reporting System 94
Lymphopenia associated with sphingosine 1-phosphate receptor modulators (S1PRMs) in multiple sclerosis: analysis of European pharmacovigilance data 93
Strengths, weaknesses and future challenges of biosimilars’ development. An opinion on how to improve the knowledge and use of biosimilars in clinical practice 93
Two Unexpected Cases of Rosacea during Fingolimod Therapy 93
PCSK9 Inhibitors and Neurocognitive Adverse Drug Reactions: Analysis of Individual Case Safety Reports from the Eudravigilance Database 93
Drugs approved for the treatment of multiple sclerosis: review of their safety profile 92
Mineralocorticoid receptor antagonists in heart failure with preserved ejection fraction (HFpEF) 90
Preventable statin adverse reactions and therapy discontinuation. What can we learn from the spontaneous reporting system? 90
Pillars and Pitfalls of the New Pharmacovigilance legislation: Consequences for the identification of adverse drug reactions deriving from abuse, misuse, overdose, occupational exposure, and medication errors 90
Renin-angiotensin system and coronavirus disease 2019: A narrative review 90
Therapeutic strategies to fight COVID-19: Which is the status artis? 90
No substantial gender differences in suspected adverse reactions to ACE inhibitors and ARBs: results from spontaneous reporting system in Campania Region 89
Surveillance of adverse events following immunization related to human papillomavirus vaccines: 12 years of vaccinovigilance in Southern Italy 88
Tisagenlecleucel in children and young adults: Reverse translational research by using real‐world safety data 87
SGLT-2 inhibitors reduce the risk of cerebrovascular/cardiovascular outcomes and mortality: A systematic review and meta-analysis of retrospective cohort studies 87
Disease-modifying therapies and hematological disorders: a systematic review of case reports and case series 86
Comparison of injective related reactions following ofatumumab and ocrelizumab in patients with multiple sclerosis: data from the European spontaneous reporting system 86
Hypernatremia During Intravenous Treatment With Fosfomycin: A Retrospective Medical Record Review Study and an Analysis of Spontaneous Reports in the EudraVigilance Database 86
Drugs-induced pathological gambling: An analysis of italian spontaneous reporting system 86
Immune Checkpoint Inhibitors and Cardiotoxicity: An Analysis of Spontaneous Reports in Eudravigilance 85
The European clinical trials regulation (No 536/2014): changes and challenges 84
Response to the comment “Is SGLT2i superior to DPP4i for primary and secondary prevention of cardiovascular diseases and death in patients with type 2 diabetes?” 84
Efficacy and Safety Profile of Diclofenac/Cyclodextrin and Progesterone/Cyclodextrin Formulations: A Review of the Literature Data 83
Preventable cases of oral anticoagulant-induced bleeding: Data from the spontaneous reporting system 83
Quinolones-Induced Musculoskeletal, Neurological, and Psychiatric ADRs: A Pharmacovigilance Study Based on Data From the Italian Spontaneous Reporting System 83
Anti-hypertensive drugs deprescribing: an updated systematic review of clinical trials 83
Real World Data on the Utilization Pattern and Safety Profile of Infliximab Originator Versus Biosimilars in Italy: A Multiregional Study 81
Response to the comment on “SGLT-2 inhibitors reduce the risk of cerebrovascular/cardiovascular outcomes and mortality: A systematic review and meta-analysis of retrospective cohort studies” 81
Vaccine Hesitancy Among Religious Groups: Reasons Underlying This Phenomenon and Communication Strategies to Rebuild Trust 80
Three Doses of COVID-19 Vaccines: A Retrospective Study Evaluating the Safety and the Immune Response in Patients with Multiple Sclerosis 80
Parental vaccine hesitancy: Recent evidences support the need to implement targeted communication strategies 79
Italian immunization goals: A political or scientific heated debate? 79
Predictors of new oral anticoagulant drug initiation as opposed to warfarin in elderly adults: A retrospective observational study in Southern Italy 79
The expanding family of c-Met inhibitors in solid tumors: a comparative analysis of their pharmacologic and clinical differences 77
The New Paradigms in Clinical Research: From Early Access Programs to the Novel Therapeutic Approaches for Unmet Medical Needs. 76
Suspected adverse reactions to contrast media in Campania Region (Italy): Results from 14 years of post-marketing surveillance 75
On the Policy of the Italian Government in the Discovery, Development, and Access to Medicines 74
Hyponatremia following Antipsychotic Treatment: In Silico Pharmacodynamics Analysis of Spontaneous Reports from the US Food and Drug Administration Adverse Event Reporting System Database and an Updated Systematic Review 73
Weight and body mass index increase in children and adolescents exposed to antipsychotic drugs in non-interventional settings: a meta-analysis and meta-regression 71
SARS-Cov-2 infection: Response of human immune system and possible implications for the rapid test and treatment 71
Severe Cutaneous Adverse Drug Reactions Associated with Allopurinol: An Analysis of Spontaneous Reporting System in Southern Italy 70
The safety profile of general and local anaesthetic agents: Data collected during 20 years of spontaneous reporting activities in the campania region (southern italy) 69
NSAIDs in patients with viral infections, including Covid-19: Victims or perpetrators? 67
SMS-Based Active Surveillance of Adverse Events following Immunization in Children: The VigiVax Study 64
Flu vaccination in multiple sclerosis patients: a monocentric prospective vaccine-vigilance study 35
null 18
Totale 9.479
Categoria #
all - tutte 31.561
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 31.561


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021230 0 0 0 0 0 17 44 22 12 9 57 69
2021/2022401 3 7 11 5 126 13 19 14 21 18 23 141
2022/2023981 134 36 18 60 107 59 6 47 467 4 25 18
2023/2024407 24 3 15 13 135 13 7 72 12 3 34 76
2024/20251.413 6 21 20 32 204 178 238 116 223 127 131 117
2025/20265.325 285 305 315 358 562 3.500 0 0 0 0 0 0
Totale 9.479